Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756985 · ClinicalTrials.gov registry record
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
A clinical trial of Glioblastoma and Glioblastoma Multiforme, sponsored by Baptist Health South Florida.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05756985 is a study of Glioblastoma and Glioblastoma Multiforme that is actively recruiting participants, run by Baptist Health South Florida. The registered enrollment target is 120 participants, above the 108-participant average among 199 other Glioblastoma trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05756985, a study of Glioblastoma and Glioblastoma Multiforme, is actively recruiting participants, sponsored by Baptist Health South Florida.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.
Conditions Studied
Interventions
- PROCEDURE Specimen Collection
Study Locations (1)
Florida
- Miami Cancer Institute at Baptist Health, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2029-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05756985
The ClinicalTrials.gov registry entry for NCT05756985 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 108-participant average among 199 other Glioblastoma trials with a reported enrollment target (11% higher). The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Glioblastoma appearing as the primary indexed condition, and to 1 intervention - of which Specimen Collection is the first listed.
NCT05756985 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05756985 about?
NCT05756985 is a clinical study titled "Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue". To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA ...
What is the current status of trial NCT05756985?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-12-11. Estimated completion is 2029-01.
What conditions does trial NCT05756985 study?
This clinical trial studies the following conditions: Glioblastoma, Glioblastoma Multiforme, Gliosarcoma.
What interventions are being tested in trial NCT05756985?
The interventions under investigation include: Specimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT05756985?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05756985 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
RECRUITING
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
RECRUITING · Phase 2
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.